DARP-36aa selectively promotes survival and morphological development of cultured mesencephalic neurons

Journal of Neuroscience

Volumn 23, Issue 1, 2003, Pages 252-259

  Smith, Sean M ^a   Ramirez, Victor D ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Catecholamine; DARP 36aa; Diencephalon; Mesencephalon; Neurotrophic factor; Tyrosine hydroxylase

Indexed keywords

DOPAMINE RELEASING PROTEIN; GENISTEIN; NEUROTROPHIC FACTOR; PEPTIDE DERIVATIVE; POLYCLONAL ANTIBODY; PROTEIN; PROTEIN TYROSINE KINASE INHIBITOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DIENCEPHALON; EMBRYO; GLIOMA CELL; IMMUNOCOMPETENT CELL; MESENCEPHALON; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

EID: 0037223305     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-01-00252.2003     Document Type: Article

References (47)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
2. Barde YA (1989) Trophic factors and neuronal survival. Neuron 2:1525-1534.
3. Beck KD, Knusel B, Hefti F (1993) The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52:855-866.
4. Benda P, Lightbody J, Sato G, Levine L, Sweet W (1968) Differentiated rat glial cell strain in tissue culture. Science 161:370-371.
5. Bottenstein J, Hayashi I, Hutchings S, Masui H, Mather J, McClure DB, Ohasa S, Rizzino A, Sato G, Serrero G, Wolfe R, Wu R (1979) The growth of cells in serum-free hormone-supplemented media. Methods Enzymol 58:94-109.
6. Burke RE, Antonelli M, Sulzer D (1998) Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J Neurochem 71:517-525.
7. Casper D, Roboz GJ, Blum M (1994) Epidermal growth factor and basic fibroblast growth factor have independent actions on mesencephalic dopamine neurons in culture. J Neurochem 62:2166-2177.
8. Chang GD, Ramirez VD (1988) A potent dopamine-releasing factor is present in high concentrations in the rat adrenal gland. Brain Res 463:385-389.
9. Choi WS, Kim MO, Ramirez VD (1993) Immunocytochemical localization of dopamine-releasing protein in the rat adrenal. Neuroendocrinology 58:440-447.
10. Choi WS, Lee BH, Ramirez VD (1994) Immunocytochemical mapping of a novel dopamine-releasing protein in the rat brain. Neuroendocrinology 60:194-204.
11. Clarkson ED, Zawada WM, Freed CR (1997) GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro. Cell Tissue Res 289:207-210.
12. Engele J, Rieck H, Choi-Lundberg D, Bohn MC (1996) Evidence for a novel neurotrophic factor for dopaminergic neurons secreted from mesencephalic glial cell lines. J Neurosci Res 43:576-586.
13. Ferrari G, Minozzi MC, Toffano G, Leon A, Skaper SD (1989) Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev Biol 133:140-147.
14. Ferrari G, Minozzi MC, Toffano G, Leon A, Skaper SD (1990) Basic fibroblast growth factor affects the survival and development of mesencephalic neurons in culture. Adv Exp Med Biol 265:93-99.
15. Gibbs RB, Pfaff DW (1994) In situ hybridization detection of trKA mRNA in brain: Distribution, colocalization with p75NGFR, and up-regulation by nerve growth factor. J Comp Neurol 341:324-339.
16. Grondin R, Gash DM (1998) Glial cell line-derived neurotrophic factor (GDNF): A drug candidate for the treatment of Parkinson's disease. J Neurol 245:35-42.
17. Horton CD, Qi Y, Chikaraishi D, Wang JK (2001) Neurotrophin-3 mediates the autocrine survival of the catecholaminergic CAD CNS neuronal cell line. J Neurochem 76:201-209.
18. Hou JG, Lin LF, Mytilineou C (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J Neurochem 66:74-82.
19. Hyman C, Juhasz M, Jackson C, Wright P, lp NY, Lindsay RM (1994) Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 14:335-347.
20. Jing Y, Waxman S (1995) Structural requirements for differentiation-induction and growth-inhibition of mouse erythroleukemia cells by isoflavones. Anticancer Res 15:1147-1152.
21. Knusel B, Michel PP, Schwaber JS, Hefti F (1990) Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitroby nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin, and the insulin-like growth factors I and II. J Neurosci 10:558-570.
22. Kokaia Z, Bengzon J, Metsis M, Kokaia M, Persson H, Lindvall O (1993) Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc Natl Acad Sci USA 90:6711-6715.
23. Korsching S (1993) The neurotrophic factor concept: A reexamination. J Neurosci 13:2739-2748.
24. Krieglstein K, Unsicker K (1997) Protein from chromaffin granules promotes survival of mesencephalic dopaminergic neurons by an EGF-receptor ligand-mediated mechanism. J Neurosci Res 48:18-30.
25. Krieglstein K, Deimling F, Suter-Crazzolara C, Unsicker K (1996) Expression and localization of GDNF in developing and adult adrenal chromaffin cells. Cell Tissue Res 286:263-268.
26. Kuhananthan S, Miklasz S, Ramirez VD (1991) Monoclonal antibodies against a dopamine-releasing protein (DARP) arrest fetal development, decrease brain catecholamines, and increase adrenal weight of neonatal rats. Mol Cell Neurosci 2:410-417.
27. Lapchak PA, Miller PJ, Jiao S, Araujo DM, Hilt D, Collins F (1996) Biology of glial cell line-derived neurotrophic factor (GDNF): Implications for the use of GDNF to treat Parkinson's disease. Neurodegeneration 5:197-205.
28. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
29. Lindholm D, Carroll P, Tzimagiogis G, Thoenen H (1996) Autocrineparacrine regulation of hippocampal neuron survival by IGF-I and the neurotrophins BDNF, NT-3, and NT-4. Eur J Neurosci 8:1452-1460.
30. Lindsay RM, Altar CA, Cedarbaum JM, Hyman C, Wiegand SJ (1993) The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp Neurol 124:103-118.
31. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS (1994) Neurotrophic factors: From molecule to man. Trends Neurosci 17:182-190.
32. Llano DA, Ramirez VD (1994) Isolation of DARP (dopamine-releasing protein) from fetal rat brain and effects of DARP immunoneutralization on fetal mesencephalic dopamine levels. Mol Cell Neurosci 5:649-657.
33. Loudes C, Petit F, Kordon C, Faivre-Bauman A (1999) Distinct populations of hypothalamic dopaminergic neurons exhibit differential responses to brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3). Eur J Neurosci 11:617-624.
34. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T (1999) Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol 57:451-484.
35. Panchision DM, Martin-DeLeon PA, Takeshima T, Johnston JM, Shimoda K, Tsoulfas P, McKay RD, Commissiong JW (1998) An immortalized, type-1 astrocyte of mesencephalic origin source of a dopaminergic neurotrophic factor. J Mol Neurosci 11:209-221.
36. Penar PL, Khoshyomn S, Bhushan A, Tritton TR (1997) Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain. Neurosurgery 40:141-151.
37. Peterson G (1995) Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125:784S-789S.
38. Smith S, Ramirez VD (1999) Cellular localization of dopamine-releasing protein (DARP) in rat C6 glioma and primary mesencephalic cell cultures. Brain Res 843:95-104.
39. Smith S, Ramirez VD (2002) Direct visualization of internalization and intracellular trafficking of dopamine-releasing protein-36aa. Neuroendocrinology 75:98-112.
40. Snider WD (1994) Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 77:627-638.
41. Studer L, Spenger C, Seiler RW, Altar CA, Lindsay RM, Hyman C (1995) Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra. Eur J Neurosci 7:223-233.
42. Suter-Crazzolara C, Lachmund A, Arab SF, Unsicker K (1996) Expression of neurotrophins and their receptors in the developing and adult rat adrenal gland. Brain Res Mol Brain Res 43:351-355.
43. Unsicker K (1993) The trophic cocktail made by adrenal chromaffin cells. Exp Neurol 123:167-173.
44. Ventimiglia R, Mather PE, Jones BE, Lindsay RM (1995a) The neurotrophins BDNF, NT-3, and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 7:213-222.
45. Ventimiglia R, Jones BE, Moller A (1995b) A quantitative method for morphometric analysis in neuronal cell culture: Unbiased estimation of neuron area and number of branch points. J Neurosci Methods 57:63-66.
46. Yang EB, Wang DF, Mack P, L. Y. C (1996) Genistein,a tyrosine kinase inhibitor, reduces EGF-induced EGF receptor internalization and degradation in human hepatoma HepG2 cells. Biochem Biophys Res Commun 224:309-317.
47. Zhou J, Shen Y, Tang Z, Xu L, Bradford HF, Yu Y (2000) Striatal extracts promote the survival and phenotypic expression of rat fetal dopaminergic neurons in vitro. Neurosci Lett 292:5-8.